Andre Limnander

Follow

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablati...
- Patent number 11,964,016
- Issue date Apr 23, 2024
- REGENERON PHARMACEUTICALS, INC.
- Seblewongel Asrat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-Fc epsilon-R1 alpha (FcεR1α) antibodies, bispecific antigen-bi...
- Patent number 11,578,127
- Issue date Feb 14, 2023
- REGENERON PHARMACEUTICALS, INC.
- Jamie M. Orengo
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-FC EPSILON-R1 ALPHA (FCER1A) ANTIBODIES, BISPECIFIC ANTIGEN-BI...
- Publication number 20230331845
- Publication date Oct 19, 2023
- Regeneron Pharmaceuticals, Inc.
- Jamie M. Orengo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF IL-4/IL-13 PATHWAY INHIBITORS AND PLASMA CELL ABLATI...
- Publication number 20200345843
- Publication date Nov 5, 2020
- Regeneron Pharmaceuticals, Inc.
- Seblewongel ASRAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-FC EPSILON-R1 ALPHA (FCER1A) ANTIBODIES, BISPECIFIC ANTIGEN-BI...
- Publication number 20200062844
- Publication date Feb 27, 2020
- Regeneron Pharmaceuticals, Inc.
- Jamie M. Orengo
- C07 - ORGANIC CHEMISTRY